Product Images Raloxifene Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Raloxifene Hydrochloride NDC 43353-253 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a report related to Percentage Change for Total Hip Bone Mineral Density Mean Percentage Change from Baseline. Study participants are divided into groups based on their intake, including raloxifene hydrochloride and placebo. The data is collected at different intervals, starting from 6 months and ending at 24 months after randomization. Another study is also mentioned, which includes hysterectomized women and the intake of conjugated estrogens. The analysis is based on "intent to treat analysis, last observation carried forward."*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.